Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Dantrolene price, strengths & recalls

Pharmacies pay $12.15 for 30 capsules of Dantrolene 25 mg capsule this week, and from $12.15 to $30.87 across its 3 priced strengths and forms. 10 manufacturers make it. It has 6 recalls on record, none ongoing. Its official label last changed on September 9, 2026.

Generic
Pharmacies pay$12.15for 30 capsules of 25 mg capsule-1.0% in 4 weeks
Fair cash price
$24.47
Strengths
3
Makers
10
Updated
Nov 11

Dantrolene price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
25 mg capsule$0.4048$12.15 / 30 capsules-1.0%+1.3%
50 mg capsule$0.5391$16.17 / 30 capsules-2.7%-19.9%
100 mg capsule$1.03$30.87 / 30 capsules+2.2%+20.0%
0.333 mg/mL injectionNot priced this week

The lowest cost per capsule is 25 mg capsule at $0.4048. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recalls6 recalls on record, latest Jun 15, 2022

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for dantrolene? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedSeptember 9, 2026
Version7 of 6
EffectiveAug 21, 2026
Read the label

Dantrolene Sodium Capsules

This drug has a boxed warning

Dantrolene sodium has a potential for hepatotoxicity, and should not be used in conditions other than those recommended. Symptomatic hepatitis (fatal and non-fatal) has been reported at various dose levels of the drug. The incidence reported in patients taking up to 400 mg/day is much lower than in those taking doses of 800 mg or more per day. Even sporadic short courses of these higher dose levels within a treatment regimen markedly increased the risk of serious hepatic injury. Liver dysfunction as evidenced by blood chemical abnormalities alone (liver enzyme elevations) has been observed in patients exposed to dantrolene sodium for varying periods of time. Overt hepatitis has occurred at varying intervals after initiation of therapy, but has been most frequently observed between the third and twelfth month of therapy. The risk of hepatic injury appears to be greater in females, in patients over 35 years of age, and in patients taking other medication(s) in addition to dantrolene sodium. Spontaneous reports suggest a higher proportion of hepatic events with fatal outcome in elderly patients receiving dantrolene sodium. However, the majority of these cases were complicated with confounding factors such as intercurrent illnesses and/or concomitant potentially hepatotoxic medications (see Geriatric Use subsection). Dantrolene sodium should be used only in conjunction with appropriate monitoring of hepatic function including frequent determination of SGOT or SGPT. If no observable benefit is derived from the administration of dantrolene sodium after a total of 45 days, therapy should be discontinued. The lowest possible effective dose for the individual patient should be prescribed.

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA017443 · Ph Health
First approved
January 15, 1974 (52 years ago)
Latest approved change
July 8, 2015
Approved label
PDF, Jul 19, 2012
Generic makers
3 approved generic applications on the market

Dantrolene questions

How much does dantrolene cost without insurance?

Pharmacies pay about $12.15 for 30 capsules of dantrolene 25 mg capsule ($0.4048 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $24.47. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is dantrolene in shortage?

No shortage is reported for dantrolene right now. We check the national shortage list every day.

Has dantrolene been recalled?

6 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the dantrolene label last change?

The official label was last updated on September 9, 2026 (version 7). See what changed.

Talk about dantrolene

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.